Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
While many individuals experience benefits within hours or days of receiving an injection, the full spectrum of advantages may unfold over several weeks
This study was based on the potent anti-inflammatory effects of BPC-157
Contemporary research applications span diverse fields including aging biology, tissue regeneration, cancer research, and regenerative medicine, with laboratory models demonstrating remarkable restoration of tissue homeostasis in both accelerated and natural aging conditions
GLP-1 carries most of the appetite effect, glucagon drives much of the liver- and visceral-fat loss, and GIP improves insulin handling while buffering some GLP-1-related nausea